SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001379402-08-000005
Filing Date
2008-03-14
Accepted
2008-03-14 17:16:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 50546
  Complete submission text file 0001379402-08-000005.txt   52288
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50514 | Film No.: 08690347
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2311 CEDAR SPRINGS ROAD, SUITE 100 DALLAS TX 75201
Business Address (817) 271-8000
Pettigrew Hal (Filed by) CIK: 0001429781 (see all company filings)

Type: SC 13G